Volume 10, Issue 4 (Nov 2022)
Res Mol Med (RMM) 2022, 10(4): 255-262 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khanbabaie G, Soltanzadeh H, Montazem H. High Expressions of MicroRNA-143 in Patients with Methamphetamine Abuse Disorder: Case-Control Study. Res Mol Med (RMM) 2022; 10 (4) :255-262
URL: http://rmm.mazums.ac.ir/article-1-482-en.html
URL: http://rmm.mazums.ac.ir/article-1-482-en.html
High Expressions of MicroRNA-143 in Patients with Methamphetamine Abuse Disorder: Case-Control Study
1- Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran
2- Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran ,hossien4040@gmail.com
2- Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran ,
Abstract: (1620 Views)
Background: Chronic drug abuse changes microRNA (miRNA) expression in the brain, which may contribute to addictive behaviors. Many miRNAs play critical roles in developing drug addiction. Methamphetamine induces various alterations in different systems by affecting gene expression, but the effects of methamphetamine on miRNA profiles need to be elucidated. This study evaluated the expression of miRNA-183 and miRNA-143 in the blood of methamphetamine abusers and controls.
Methods: In this case-control study, the case group comprised 60 people with a methamphetamine addiction from Tabriz City, East Azerbaijan, Iran, and the control group comprised 60 healthy controls of comparable ages and ethnicities. Total RNA was extracted from peripheral blood samples, and then cDNA was synthesized. MicroRNA-183 and microRNA-143 expression levels were determined using real-time PCR.
Results: The results indicated that methamphetamine abusers had significantly higher blood levels of miRNA-143 than healthy controls (P<0.05); however, miRNA-183 expression was comparable between the two groups (P>0.05).
Conclusion: MicroRNA-143 may play a role in the pathology of methamphetamine abuse, so it may be used as an additional method to identify people with an addiction precisely.
Methods: In this case-control study, the case group comprised 60 people with a methamphetamine addiction from Tabriz City, East Azerbaijan, Iran, and the control group comprised 60 healthy controls of comparable ages and ethnicities. Total RNA was extracted from peripheral blood samples, and then cDNA was synthesized. MicroRNA-183 and microRNA-143 expression levels were determined using real-time PCR.
Results: The results indicated that methamphetamine abusers had significantly higher blood levels of miRNA-143 than healthy controls (P<0.05); however, miRNA-183 expression was comparable between the two groups (P>0.05).
Conclusion: MicroRNA-143 may play a role in the pathology of methamphetamine abuse, so it may be used as an additional method to identify people with an addiction precisely.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
